165 related articles for article (PubMed ID: 14963370)
1. Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma.
Martin Chaves EB; Brum IS; Stoll J; Capp E; Corleta Hv
Gynecol Obstet Invest; 2004; 57(4):210-3. PubMed ID: 14963370
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and tyrosine kinase activity of insulin receptor in uterine leiomyoma and matched myometrium.
Toscani GK; Chaves EM; Cervi FL; Tavares MB; Silva IS; von Eye Corleta H; Capp E
Arch Gynecol Obstet; 2004 Nov; 270(3):170-3. PubMed ID: 12937923
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor tyrosine kinase activity and substrate 1 (IRS-1) expression in human myometrium and leiomyoma.
Orcy RB; Brum I; da Silva RS; Kucharski LC; Corleta Hv; Capp E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):107-10. PubMed ID: 16260343
[TBL] [Abstract][Full Text] [Related]
4. Dual actions of progesterone on uterine leiomyoma correlate with the ratio of progesterone receptor A:B.
Ying Z; Weiyuan Z
Gynecol Endocrinol; 2009 Aug; 25(8):520-3. PubMed ID: 19499404
[TBL] [Abstract][Full Text] [Related]
5. The expression of estrogen receptor isoforms alpha, beta and insulin-like growth factor-I in uterine leiomyoma.
Zhao Y; Zhang W; Wang S
Gynecol Endocrinol; 2008 Oct; 24(10):549-54. PubMed ID: 19012097
[TBL] [Abstract][Full Text] [Related]
6. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
8. [Affect of insulin-like growth factor I and estradiol on the growth of uterine leiomyoma].
Huang J; Zou J; Xu B; Zhang Y; Chen X; Liu D
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):29-32. PubMed ID: 11938733
[TBL] [Abstract][Full Text] [Related]
9. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.
Vollenhoven BJ; Herington AC; Healy DL
J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390
[TBL] [Abstract][Full Text] [Related]
10. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
Yamada T; Nakago S; Kurachi O; Wang J; Takekida S; Matsuo H; Maruo T
Hum Reprod; 2004 Apr; 19(4):815-21. PubMed ID: 15033949
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas.
Rodríguez Y; Almeida TA; Valladares F; Báez D; Montes de Oca F; García C; Dorta I; Hernández M; Reyes R; Bello AR
Biol Reprod; 2010 Oct; 83(4):641-7. PubMed ID: 20592307
[TBL] [Abstract][Full Text] [Related]
12. Gene and protein expression of progesterone receptor isoforms A and B, p53 and p21 in myometrium and uterine leiomyoma.
Lora V; Grings AO; Capp E; von Eye Corleta H; Brum IS
Arch Gynecol Obstet; 2012 Jul; 286(1):119-24. PubMed ID: 22350293
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of IGF-I signaling in uterine leiomyoma.
Burroughs KD; Howe SR; Okubo Y; Fuchs-Young R; LeRoith D; Walker CL
J Endocrinol; 2002 Jan; 172(1):83-93. PubMed ID: 11786376
[TBL] [Abstract][Full Text] [Related]
14. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth.
Wolańska M; Bańkowski E
Eur Cytokine Netw; 2004; 15(4):359-63. PubMed ID: 15627646
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
17. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues.
Boehm KD; Daimon M; Gorodeski IG; Sheean LA; Utian WH; Ilan J
Mol Reprod Dev; 1990 Oct; 27(2):93-101. PubMed ID: 1979007
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
[TBL] [Abstract][Full Text] [Related]
19. Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata.
Tommola P; Pekonen F; Rutanen EM
Obstet Gynecol; 1989 Oct; 74(4):658-62. PubMed ID: 2797644
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
